RE: Tweet reply22 Oct 2023 12:12
Darwen .,.. You are 100% right on vlad and guess what nothing anyone says on here will change that. He has god syndrome, is a maverick ceo (thinks he is like Elon musk and we hope he finally is) and has a continued habit of over promising and under delivering. Where HEMO is now is definately not where it was in 2017 but there is still some major overhang in trusted vlad based on the past. Why? Because the number of new investors in hemo are limited and this price is being propped up by LTHs like us and a great job by traders enjoying their measerly 5 - 10% very week.
Nevertheless, the past is the past and Vlad has a real chance of finally delivering something to the market and allowing shareholders to forget the past. We don't know what type of price this will be when IND is approved but if marketing finally does a good job, it will attract huge new institutional investor, return trust in hemo actually becoming a clinical company and there will be a frenzy to buy into this stock. CBR will then be the rocket and whether funding comes from the market or from partners like prevail it will be irrelevant since there will be plenty of people who will want the stock.
I share your frustration my friend and I am not supporter of the CEO but this is now the time to just wait ... days or weeks and hopefully hopefully we can put the bad decisions of the CEO in the past to bed !!!!